Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
GenoVive partners with Deoxi of Brazil
NEW ORLEANS, July 10, 2014 /PRNewswire/ -- GenoVive, a company with a revolutionary gene-based approach to weight management, announced a new partnership with Deoxi Biotecnologia of Brazil to offer its personalized health program in South America. GenoVive is the first in its field to design diet and fitness regiments for individuals based on the unique genetic information found in their DNA. With this new partnership, GenoVive has a presence in six countries, including Brazil, Dominican Republic, Mexico, Poland, Saudi Arabia, and the United States.
Deoxi is a reference company in the field of genomic technologies in Brazil. It provides services in the field of molecular biology, especially in the identification of DNA markers.
"Recent scientific advances in genomics are changing how people manage their health; the use of genetic information to assist in health is a reality," said Dr. Rodrigo Alonso (Deoxi Executive Director). "Our partnership with GenoVive will allow us to expand our offerings and position our company at the forefront of this new era of personalized healthcare."
GenoVive's program starts simply enough with an at home DNA kit; the client simply swabs the inside of his or her mouth. The DNA sample is sent to GenoVive's CLIA certified lab where it is analyzed. GenoVive then creates a genetically optimized diet and exercise program that lays out the best combination of macronutrients and exercise intensity level for the individual. The client is given a report with specific recommendations for an ideal diet and exercise program best suited to his or her individual physiology and metabolism.
"We are delighted to have such a well known and respected partner to expand our personalized program to combat globesity in Brazil, which is deeply affecting the majority of Brazilian healthcare costs," states Victor Castellon, PharmD, CEO and founder of GenoVive USA.
Metabolism and body weight are based largely on the genes that one inherits from ones parents. Everyone's body is different, and so too should be the way that we eat and exercise. GenoVive uses an individual's DNA to design a diet and exercise plan specifically for them. This personalized approach means more weight loss in less time. For more information, please visit www.GenoVive.com.
Founded in 2008, Deoxi Biotecnologia Ltda is a private Brazilian company created to develop innovative biotechnology products and processes through integration of scientific knowledge, advanced technology and strategic management. With multidisciplinary technical team and extensive international scientific network, the company operates in R&D projects in the ??human pharmacogenomics, submicroscopic chromosomal alterations associated with intellectual disabilities, and more recently in nutrigenetics.
For more information, please visit http://www.deoxi.com.br.
©2012 PR Newswire. All Rights Reserved.